Psychiatric Disorders
The clinical research activity is centered on treatment-resistant depression, with interest in interventions for patients whose depressive symptoms have not responded adequately to standard care.
- Treatment-resistant depression
- Depressive symptom management
- Refractory mood disorders
The sponsor’s trial portfolio in this area reflects a focus on advancing clinical options for major depressive disorder when conventional therapies are insufficient.
Psychopharmacology
Research interest includes the therapeutic evaluation of psilocybin within a mental health setting, examining its role in addressing persistent depressive illness.
- Psilocybin
- Novel antidepressant approaches
- Serotonergic modulation
This area places emphasis on emerging psychedelic-based therapies for psychiatric conditions with limited treatment responsiveness.
Mental Health Care
The sponsor is engaged in clinical investigation relevant to specialist psychiatric care, with attention to patients requiring alternative therapeutic strategies for severe depressive symptoms.
- Specialist psychiatric treatment
- Severe depression
- Unmet mental health needs
Its research activity is aligned with hospital-based care for complex mood disorders managed in a clinical setting.
